Cancer Health Treatment Update Can Cancer Medications Treat COVID-19? Studies suggest BTK inhibitors and hormone therapy might lessen disease severity and speed recovery. Cancer Health at Home: Coping with COVID-19 and Cancer Join Cancer Health bloggers Megan-Claire Chase, Robin McGee and Jeff Neurman for our first live Zoom/Facebook event. Thursday 7/23 at 7 p.m. ET. Cancer-Causing ‘Frankengene’ Mutation Could Be Target For New Drugs This gene is fused to many partner genes in different tumors. Now, scientists know it causes cancer—and how they might intervene.  Tecentriq Plus Avastin Now Approved for Liver Cancer The combination improved both overall survival and patient-reported outcomes in a clinical trial. Coronavirus Vaccines Show Promise in Early Studies Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials. For all of Cancer Health's coverage of the novel coronavirus and COVID-19, including how they affect people living with cancer, click here. News from the AACR Virtual Annual Meeting See all our reports from this major cancer research conference. Cancer Health Summer 2020 Check out our new print edition! Advertisement Newsfeed Why Prisoners Are More Likely to Die of COVID-19 Cancer and HIV Groups Urge Trump Not to Remove U.S. From the WHO The 15 White Coats, a Group of Black Med Students, Aims for Racial Reform in Medicine Ruth Bader Ginsburg Is Being Treated for Cancer Recurrence Blog: Food and Drug Administration (FDA) FDA Program Will Communicate Patient Reported Outcomes from Cancer Clinical Trials FDA Approves Opdivo for Esophageal Cancer FDA Approves Cyramza Plus Tarceva for First-Line Lung Cancer Treatment FDA Approves Opdivo Plus Yervoy With Chemotherapy for Metastatic Lung Cancer Newsfeed Why Prisoners Are More Likely to Die of COVID-19 Cancer and HIV Groups Urge Trump Not to Remove U.S. From the WHO The 15 White Coats, a Group of Black Med Students, Aims for Racial Reform in Medicine Ruth Bader Ginsburg Is Being Treated for Cancer Recurrence Blog: Food and Drug Administration (FDA) FDA Program Will Communicate Patient Reported Outcomes from Cancer Clinical Trials FDA Approves Opdivo for Esophageal Cancer FDA Approves Cyramza Plus Tarceva for First-Line Lung Cancer Treatment FDA Approves Opdivo Plus Yervoy With Chemotherapy for Metastatic Lung Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: